Regulatory Application

24 December 2002 Joh.A.Benckiser Exchanges `A' Shares into Ordinary Shares Reckitt Benckiser plc announced today that its largest shareholder, Joh A Benckiser GmbH (JAB) is exercising its rights to exchange 13,655,000 `A' shares in Reckitt Benckiser Holdings BV (the A Shares) into 68,275,000 ordinary shares in Reckitt Benckiser plc. This will result in the cancellation of the special voting share and complete the transitional arrangements from the merger of Benckiser NV and Reckitt & Colman plc in 1999. At the time of the merger in 1999, JAB held two shareholdings in Benckiser NV (BNV). One of these holdings was exchanged into Reckitt Benckiser plc (RB) ordinary shares at that time in the ratio of 5 RB shares for 1BNV, the ratio on which the merger of equals was executed. The other holding, of 13,655,000 BNV `A' shares, could not be converted at that time for complex domicile and tax reasons. It was therefore temporarily left as an equal number of shares in Reckitt Benckiser Holdings BV, with the right to exchange into RB shares on the same ratio of 5 to1 at any time until 30 September 2005. At the same time, JAB was granted a special voting share, conferring rights directly in RB equivalent to these shares in respect of voting entitlement, which would be cancelled once these shares were exchanged. This arrangement, covered by a shareholder agreement, was fully disclosed in the merger documents and in subsequent annual reports. Following these exchanges, JAB will hold 171,105,415 ordinary shares in Reckitt Benckiser plc (24.3% of the total issued share capital) and voting and dividend rights equating only to this direct holding. Under the shareholder agreement, JAB has the right to nominate two non-executive members of the Board of RB as long as it holds 20% or more, and one non-executive as long as it holds more than 10% of the issued share capital. Two current non-executives, Peter Harf and Dieter Meuderscheid, are considered to have been nominated by, and to represent, JAB. As a result of the exchanges, the number of ordinary shares in issue in Reckitt Benckiser plc will increase by 68,275,000 to 705m, and the official market capitalisation of the Company will increase accordingly. However these exchanges will have no impact on the earnings per share, dividend payment or other economic interests of the Company. This is because RB has, in order to show a true a fair view, included the amounts attributable to the `A' shares as if they had been exchanged for RB ordinary shares in calculating earnings per share and all other per share data, and in paying ordinary dividends since the merger in 1999. The details of this previous treatment are fully disclosed in the Accounting Policies in the Annual Report (p.30 in the 2001 Annual Report). Application has been made to the UK Listing Authority for the ordinary shares arising fromthe exchanges to be admitted to the Official List and to the London Stock Exchange for them to be traded. It is expected that admission will become effective and trading will commence as follows: 63,000,000 ordinary shares on 27 December 2002 5,275,000 ordinary shares on 31 December 2002 For further information Tom Corran SVP Investor Relations & Corporate Communications +44 (0)1753 217 800 www.reckittbenckiser.com
UK 100

Latest directors dealings